ACORDA THERAPEUTICS
Acorda Therapeutics, Inc. (Acorda) is a commercial-stage biopharmaceutical company engaged in the identification, development and commercialization of therapies that improve neurological function in people with multiple sclerosis (MS), spinal cord injury (SCI) and other disorders of the nervous system. The first product for which the Company completed clinical development, Ampyra (dalfampridine) Extended Release Tablets (Ampyra), was approved by the United States Food and Drug Administration (FD... A) in January 2010, as a treatment to improve walking in patients with MS. Ampyra is an extended-release tablet formulation of dalfampridine (4-aminopyridine (4-AP)), which was previously referred to as fampridine. Acorda's marketed product, Zanaflex Capsules, is approved by the FDA as a short-acting drug for the management of spasticity.
ACORDA THERAPEUTICS
Industry:
Biotechnology Developer Platform Health Care
Founded:
1995-01-01
Address:
Hawthorne, New York, United States
Country:
United States
Website Url:
http://www.acorda.com
Total Employee:
251+
Status:
Active
Contact:
(914) 347-4300
Email Addresses:
[email protected]
Total Funding:
151.6 M USD
Technology used in webpage:
Domain Not Resolving Google Maps Mobile Non Scaleable Content HSTS IPv6 Cloudflare Hosting JsDelivr Apache Cloudflare JS CDN JS
Similar Organizations
PolyCore Therapeutics
PolyCore Therapeutics’ team of life sciences scientists is dedicated to developing breakthrough treatments for CNS Diseases.
XOMA
XOMA is at the forefront of antibody discovery and development, one of the most powerful and transformative fields of drug innovation
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-01-19 | Biotie Therapies | Biotie Therapies acquired by Acorda Therapeutics | 363 M USD |
| 2014-09-24 | Civitas Therapeutics | Civitas Therapeutics acquired by Acorda Therapeutics | 525 M USD |
| 2012-02-17 | Neuronex | Neuronex acquired by Acorda Therapeutics | N/A |
Investors List
Paul Capital
Paul Capital investment in Post-IPO Equity - Acorda Therapeutics
National Institute of Neurological Disorders and Stroke
National Institute of Neurological Disorders and Stroke investment in Grant - Acorda Therapeutics
New York State Department of Health
New York State Department of Health investment in Grant - Acorda Therapeutics
Cross Atlantic Partners
Cross Atlantic Partners investment in Series B - Acorda Therapeutics
J.P. Morgan Securities Inc.
J.P. Morgan Securities Inc. investment in Series B - Acorda Therapeutics
Forbion Capital Partners
Forbion Capital Partners investment in Series B - Acorda Therapeutics
MPM Capital
MPM Capital investment in Series B - Acorda Therapeutics
Techno Venture Management
Techno Venture Management investment in Series B - Acorda Therapeutics
Forward Ventures
Forward Ventures investment in Series B - Acorda Therapeutics
ABN AMRO Fund
ABN AMRO Fund investment in Series B - Acorda Therapeutics
Official Site Inspections
http://www.acorda.com Semrush global rank: 2.9 M Semrush visits lastest month: 5.6 K
- Host name: 44.233.12.198.host.secureserver.net
- IP address: 198.12.233.44
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Acorda Therapeutics"
Acorda Pharmaceuticals | Quality Medicines for a Healthier Life
Acorda Pharmaceuticals is dedicated to providing high-quality and innovative healthcare solutions. We focus on safety, and excellence to develop effective medicines that enhance …See details»
As of July 10, 2024, AMPYRA® (dalfampridine), INBRIJAÂ
As of August 21, 2024 Acorda Therapeutics Inc. exited Chapter 11 bankruptcy and all remaining assets are now the property of Acorda Therapeutics Liquidation Trust.See details»
Acorda Therapeutics - Wikipedia
Acorda Therapeutics was incorporated in 1995, founded by internist turned entrepreneur Ron Cohen in Hawthorne, New York. Cohen had previously worked at the tissue engineering firm Advanced Tissue Sciences from 1986 to 1992. Cohen's focus on neurology at Acorda was influenced by his father's being a neurologist at Columbia University Medical Center. The business model of the company from the start was to work on commercialization of academic discoveries…See details»
Our Community - acorda.com
Acorda is committed to improving neurological function and the communities we serve. We participate in national and local community events throughout the year; and we support …See details»
Scientific Excellence - acorda.com
At Acorda Scientific Excellence Our goal is to be the leading biopharmaceutical company developing and marketing therapies that improve, repair, and restore neurological function in …See details»
Acorda Therapeutics - Crunchbase Company Profile & Funding
Acorda Therapeutics, Inc. (Acorda) is a commercial-stage biopharmaceutical company engaged in the identification, development and commercialization of therapies that improve neurological …See details»
Acorda Online Reports - Letter from the ceo
Acorda’s Leadership Team, Board of Directors, and associates took decisive actions in 2017, and as a result Acorda has emerged in 2018 as a streamlined organization with a strong cash …See details»
Acorda Therapeutics, Inc. Company Profile | Pearl River, NY ...
Company Description: Acorda Therapeutics is a biopharmaceutical company focused on developing prescription drugs that aim to restore neurological function for patients with central …See details»
Acorda Therapeutics - Leadership Team - The Org
The Leadership Team at Acorda Therapeutics is responsible for guiding the company's strategic direction and fostering a collaborative culture. Comprising executives from various disciplines …See details»
Acorda Therapeutics - The Org
Acorda Therapeutics is a publicly-traded (NASDAQ: ACOR) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of …See details»
Acorda Therapeutics 2025 Company Profile: Valuation, Investors ...
Acorda Therapeutics Inc is a biopharmaceutical company engaged in developing therapies that restore function and improve the lives of people with neurological disorders. The company …See details»
Leadership ← Acorda
Management Team Ron Cohen, M.D. President and Chief Executive Officer Andrew R. Blight, Ph.D. Chief Scientific Officer Enrique Carrazana, M.D. Chief Medical OfficerSee details»
Ron Cohen, M.D. - Advanced Therapeutics in Movement
Ron Cohen, M.D. is President, CEO and founder of Acorda Therapeutics, Inc., a public biotechnology company developing therapies for disorders of the nervous system, including …See details»
Acorda Therapeutics | IT History Society
Acorda Therapeutics began in 1995 as a network of scientists, physicians and business people with a common belief.Acorda Therapeutics, Inc. (Acorda) is a commercial-stage …See details»
Acorda Therapeutics, Inc. Information - RocketReach
Acorda Therapeutics is a publicly traded (NASDAQ: ACOR) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of …See details»
CODE OF ETHICS - Acorda Therapeutics
Acorda managers and supervisors have a special responsibility to maintain and communicate this Code consistently. They must create a work environment that encourages ethical behavior and …See details»
Acorda Therapeutics Company Profile, Stock Price, News, Rankings …
Acorda Therapeutics. Company Information Millennials In The Organization Women In The Organization. Company Information. Company Information; Millennials In The Organization;See details»
Working At Acorda
Working At Acorda. Acorda Therapeutics, Inc. has been recognized as one of the "Best Companies to Work for in New York" and named to the "Deloitte Technology Fast 500 ™" for …See details»
Acorda Therapeutics - Craft
Jun 13, 2024 Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders. Acorda has …See details»
Acorda Comprehensive Compliance Program Final12-19-14
Acorda Therapeutics, Inc. Comprehensive Compliance Plan Acorda Therapeutics, Inc. (“Acorda,” “The Company”) is committed to ensuring its interactions with healthcare professionals adhere …See details»